Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Comparison of Synthetic Media Designed for Expansion of Adipose-Derived Mesenchymal Stromal Cells.

Lensch M, Muise A, White L, Badowski M, Harris D.

Biomedicines. 2018 May 14;6(2). pii: E54. doi: 10.3390/biomedicines6020054.

2.

Dysphagia in Mechanically Ventilated ICU Patients (DYnAMICS): A Prospective Observational Trial.

Schefold JC, Berger D, Zürcher P, Lensch M, Perren A, Jakob SM, Parviainen I, Takala J.

Crit Care Med. 2017 Dec;45(12):2061-2069. doi: 10.1097/CCM.0000000000002765.

3.

Corrigendum: Hallmarks of pluripotency.

De Los Angeles A, Ferrari F, Xi R, Fujiwara Y, Benvenisty N, Deng H, Hochedlinger K, Jaenisch R, Lee S, Leitch HG, Lensch MW, Lujan E, Pei D, Rossant J, Wernig M, Park PJ, Daley GQ.

Nature. 2016 Mar 17;531(7594):400. doi: 10.1038/nature16470. Epub 2015 Dec 16. No abstract available.

PMID:
26675727
4.

Hallmarks of pluripotency.

De Los Angeles A, Ferrari F, Xi R, Fujiwara Y, Benvenisty N, Deng H, Hochedlinger K, Jaenisch R, Lee S, Leitch HG, Lensch MW, Lujan E, Pei D, Rossant J, Wernig M, Park PJ, Daley GQ.

Nature. 2015 Sep 24;525(7570):469-78. doi: 10.1038/nature15515. Review. Erratum in: Nature. 2016 Mar 17;531(7594):400.

PMID:
26399828
5.

Interference of angiotensin II and enalapril with hepatic blood flow regulation.

Pereira AJ, Jeger V, Fahrner R, Djafarzadeh S, Lensch M, Takala J, Jakob SM.

Am J Physiol Gastrointest Liver Physiol. 2014 Sep 15;307(6):G655-63. doi: 10.1152/ajpgi.00150.2014. Epub 2014 Jul 24.

6.

From stealing fire to cellular reprogramming: a scientific history leading to the 2012 Nobel Prize.

Lensch MW, Mummery CL.

Stem Cell Reports. 2013 Jun 4;1(1):5-17. doi: 10.1016/j.stemcr.2013.05.001. Review.

7.

Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction.

Tulpule A, Kelley JM, Lensch MW, McPherson J, Park IH, Hartung O, Nakamura T, Schlaeger TM, Shimamura A, Daley GQ.

Cell Stem Cell. 2013 Jun 6;12(6):727-36. doi: 10.1016/j.stem.2013.04.002. Epub 2013 Apr 18.

8.

Signaling axis involving Hedgehog, Notch, and Scl promotes the embryonic endothelial-to-hematopoietic transition.

Kim PG, Albacker CE, Lu YF, Jang IH, Lim Y, Heffner GC, Arora N, Bowman TV, Lin MI, Lensch MW, De Los Angeles A, Zon LI, Loewer S, Daley GQ.

Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):E141-50. doi: 10.1073/pnas.1214361110. Epub 2012 Dec 12.

9.

Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis.

Corrêa TD, Vuda M, Blaser AR, Takala J, Djafarzadeh S, Dünser MW, Silva E, Lensch M, Wilkens L, Jakob SM.

Crit Care Med. 2012 Oct;40(10):2841-9.

PMID:
22890256
10.

An evolving model of hematopoietic stem cell functional identity.

Lensch MW.

Stem Cell Rev. 2012 Jun;8(2):551-60. doi: 10.1007/s12015-012-9347-x. Review.

PMID:
22278132
11.

Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells.

Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, Huo H, Loh YH, Aryee MJ, Lensch MW, Li H, Collins JJ, Feinberg AP, Daley GQ.

Nat Biotechnol. 2011 Nov 27;29(12):1117-9. doi: 10.1038/nbt.2052. Erratum in: Nat Biotechnol. 2012 Jan;30(1):112.

12.

Public perception of stem cell and genomics research.

Lensch MW.

Genome Med. 2011 Jul 6;3(7):44. doi: 10.1186/gm260. No abstract available.

13.

Adhesion/growth-regulatory galectins: insights into their ligand selectivity using natural glycoproteins and glycotopes.

Wu AM, Singh T, Liu JH, André S, Lensch M, Siebert HC, Krzeminski M, Bonvin AM, Kaltner H, Wu JH, Gabius HJ.

Adv Exp Med Biol. 2011;705:117-41. doi: 10.1007/978-1-4419-7877-6_7. No abstract available.

PMID:
21618107
14.

Investigating monogenic and complex diseases with pluripotent stem cells.

Zhu H, Lensch MW, Cahan P, Daley GQ.

Nat Rev Genet. 2011 Apr;12(4):266-75. doi: 10.1038/nrg2951. Epub 2011 Mar 9. Review.

PMID:
21386866
15.

Toward comprehensive analysis of the galectin network in chicken: unique diversity of galectin-3 and comparison of its localization profile in organs of adult animals to the other four members of this lectin family.

Kaltner H, Kübler D, López-Merino L, Lohr M, Manning JC, Lensch M, Seidler J, Lehmann WD, André S, Solís D, Gabius HJ.

Anat Rec (Hoboken). 2011 Mar;294(3):427-44. doi: 10.1002/ar.21341. Epub 2011 Feb 2.

16.

Human galectin-3 (Mac-2 antigen): defining molecular switches of affinity to natural glycoproteins, structural and dynamic aspects of glycan binding by flexible ligand docking and putative regulatory sequences in the proximal promoter region.

Krzeminski M, Singh T, André S, Lensch M, Wu AM, Bonvin AM, Gabius HJ.

Biochim Biophys Acta. 2011 Feb;1810(2):150-61. doi: 10.1016/j.bbagen.2010.11.001. Epub 2010 Nov 8.

PMID:
21070836
17.

Analysis of monoPEGylated human galectin-2 by small-angle X-ray and neutron scattering: concentration dependence of PEG conformation in the conjugate.

He L, Wang H, Garamus VM, Hanley T, Lensch M, Gabius HJ, Fee CJ, Middelberg A.

Biomacromolecules. 2010 Dec 13;11(12):3504-10. doi: 10.1021/bm100999a. Epub 2010 Nov 4.

PMID:
21049922
18.

Induced pluripotent stem cells: opportunities and challenges.

Lensch MW, Rao M.

Regen Med. 2010 Jul;5(4):483-4. doi: 10.2217/rme.10.49. No abstract available.

19.

Reprogramming of T cells from human peripheral blood.

Loh YH, Hartung O, Li H, Guo C, Sahalie JM, Manos PD, Urbach A, Heffner GC, Grskovic M, Vigneault F, Lensch MW, Park IH, Agarwal S, Church GM, Collins JJ, Irion S, Daley GQ.

Cell Stem Cell. 2010 Jul 2;7(1):15-9. doi: 10.1016/j.stem.2010.06.004. No abstract available.

20.

N-domain of human adhesion/growth-regulatory galectin-9: preference for distinct conformers and non-sialylated N-glycans and detection of ligand-induced structural changes in crystal and solution.

Solís D, Maté MJ, Lohr M, Ribeiro JP, López-Merino L, André S, Buzamet E, Cañada FJ, Kaltner H, Lensch M, Ruiz FM, Haroske G, Wollina U, Kloor M, Kopitz J, Sáiz JL, Menéndez M, Jiménez-Barbero J, Romero A, Gabius HJ.

Int J Biochem Cell Biol. 2010 Jun;42(6):1019-29. doi: 10.1016/j.biocel.2010.03.007. Epub 2010 Mar 19.

PMID:
20227520
21.

Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage.

Tulpule A, Lensch MW, Miller JD, Austin K, D'Andrea A, Schlaeger TM, Shimamura A, Daley GQ.

Blood. 2010 Apr 29;115(17):3453-62. doi: 10.1182/blood-2009-10-246694. Epub 2010 Jan 20.

22.

Carbamate-linked lactose: design of clusters and evidence for selectivity to block binding of human lectins to (neo)glycoproteins with increasing degree of branching and to tumor cells.

André S, Specker D, Bovin NV, Lensch M, Kaltner H, Gabius HJ, Wittmann V.

Bioconjug Chem. 2009 Sep;20(9):1716-28. doi: 10.1021/bc900152w.

PMID:
19715307
23.

Immunohistochemical fingerprinting of the network of seven adhesion/growth-regulatory lectins in human skin and detection of distinct tumour-associated alterations.

Cada Z, Smetana K Jr, Lacina L, Plzáková Z, Stork J, Kaltner H, Russwurm R, Lensch M, André S, Gabius HJ.

Folia Biol (Praha). 2009;55(4):145-52.

24.

Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.

Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, Ryeom S.

Nature. 2009 Jun 25;459(7250):1126-30. doi: 10.1038/nature08062. Epub 2009 May 20.

25.

Biomechanical forces promote embryonic haematopoiesis.

Adamo L, Naveiras O, Wenzel PL, McKinney-Freeman S, Mack PJ, Gracia-Sancho J, Suchy-Dicey A, Yoshimoto M, Lensch MW, Yoder MC, García-Cardeña G, Daley GQ.

Nature. 2009 Jun 25;459(7250):1131-5. doi: 10.1038/nature08073. Epub 2009 May 13.

26.

Cellular reprogramming and pluripotency induction.

Lensch MW.

Br Med Bull. 2009;90:19-35. doi: 10.1093/bmb/ldp011. Epub 2009 Apr 17. Review.

PMID:
19376801
27.

Unique chicken tandem-repeat-type galectin: implications of alternative splicing and a distinct expression profile compared to those of the three proto-type proteins.

Kaltner H, Solís D, André S, Lensch M, Manning JC, Mürnseer M, Sáiz JL, Gabius HJ.

Biochemistry. 2009 May 26;48(20):4403-16. doi: 10.1021/bi900083q.

PMID:
19344160
28.

Broader implications of defining standards for the pluripotency of iPSCs.

Daley GQ, Lensch MW, Jaenisch R, Meissner A, Plath K, Yamanaka S.

Cell Stem Cell. 2009 Mar 6;4(3):200-1; author reply 202. doi: 10.1016/j.stem.2009.02.009. No abstract available.

29.

Detection and chromatographic removal of lipopolysaccharide in preparations of multifunctional galectins.

Sarter K, André S, Kaltner H, Lensch M, Schulze C, Urbonaviciute V, Schett G, Herrmann M, Gabius HJ.

Biochem Biophys Res Commun. 2009 Jan 30;379(1):155-9. doi: 10.1016/j.bbrc.2008.12.024. Epub 2008 Dec 25.

PMID:
19101505
30.

Galectin-7: will the lectin's activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas?

Cada Z, Chovanec M, Smetana K, Betka J, Lacina L, Plzák J, Kodet R, Stork J, Lensch M, Kaltner H, André S, Gabius HJ.

Histol Histopathol. 2009 Jan;24(1):41-8. doi: 10.14670/HH-24.41.

PMID:
19012243
31.

Single-site Cys-substituting mutation of human lectin galectin-2: modulating solubility in recombinant production, reducing long-term aggregation, and enabling site-specific monoPEGylation.

Wang H, He L, Lensch M, Gabius HJ, Fee CJ, Middelberg AP.

Biomacromolecules. 2008 Nov;9(11):3223-30. doi: 10.1021/bm800801b. Epub 2008 Oct 23.

PMID:
18942878
32.

Disease-specific induced pluripotent stem cells.

Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ.

Cell. 2008 Sep 5;134(5):877-86. doi: 10.1016/j.cell.2008.07.041. Epub 2008 Aug 7.

33.

Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresia/luteolysis in contrast to pro-apoptotic galectins-1 and -7.

Lohr M, Kaltner H, Lensch M, André S, Sinowatz F, Gabius HJ.

Histochem Cell Biol. 2008 Sep;130(3):567-81. doi: 10.1007/s00418-008-0465-0. Epub 2008 Jul 3.

PMID:
18597104
34.

Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera.

Lensch MW, Schlaeger TM, Zon LI, Daley GQ.

Cell Stem Cell. 2007 Sep 13;1(3):253-8. doi: 10.1016/j.stem.2007.07.019. Epub 2007 Aug 23.

35.

Human galectins as sensors for apoptosis/necrosis-associated surface changes of granulocytes and lymphocytes.

Beer A, André S, Kaltner H, Lensch M, Franz S, Sarter K, Schulze C, Gaipl US, Kern P, Herrmann M, Gabius HJ.

Cytometry A. 2008 Feb;73(2):139-47. doi: 10.1002/cyto.a.20510.

36.

Looking into the future of cell-based therapy.

Lensch MW, West JA.

South Med J. 2008 Jan;101(1):79-82. doi: 10.1097/SMJ.0b013e31815d4201.

PMID:
18176297
37.

Reprogramming of human somatic cells to pluripotency with defined factors.

Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ.

Nature. 2008 Jan 10;451(7175):141-6. Epub 2007 Dec 23.

PMID:
18157115
38.

Human galectin-2: nuclear presence in vitro and its modulation by quiescence/stress factors.

Dvoránková B, Lacina L, Smetana K Jr, Lensch M, Manning JC, André S, Gabius HJ.

Histol Histopathol. 2008 Feb;23(2):167-78. doi: 10.14670/HH-23.167.

PMID:
17999373
39.

The terminology of teratocarcinomas and teratomas.

Lensch MW, Ince TA.

Nat Biotechnol. 2007 Nov;25(11):1211; author reply 1211-2. No abstract available.

PMID:
17989663
40.

Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance.

Langbein S, Brade J, Badawi JK, Hatzinger M, Kaltner H, Lensch M, Specht K, André S, Brinck U, Alken P, Gabius HJ.

Histopathology. 2007 Nov;51(5):681-90.

PMID:
17927590
41.

Current prospects for the generation of patient-specific pluripotent cells from adult tissues.

Agarwal S, Lensch MW, Daley GQ.

Regen Med. 2007 Sep;2(5):743-52. No abstract available.

42.

Prototype chicken galectins revisited: characterization of a third protein with distinctive hydrodynamic behaviour and expression pattern in organs of adult animals.

Kaltner H, Solís D, Kopitz J, Lensch M, Lohr M, Manning JC, Mürnseer M, Schnölzer M, André S, Sáiz JL, Gabius HJ.

Biochem J. 2008 Jan 15;409(2):591-9.

PMID:
17887955
44.

Hemogenic endothelial progenitor cells isolated from human umbilical cord blood.

Wu X, Lensch MW, Wylie-Sears J, Daley GQ, Bischoff J.

Stem Cells. 2007 Nov;25(11):2770-6. Epub 2007 Jul 19.

45.

Pluripotent stem cells and their niches.

Lensch MW, Daheron L, Schlaeger TM.

Stem Cell Rev. 2006;2(3):185-201. Review.

PMID:
17625255
46.

Human embryonic stem cells flock together.

Lensch MW, Daley GQ.

Nat Biotechnol. 2007 Jul;25(7):748-50. No abstract available.

PMID:
17621300
47.

Science aside: the trajectory of embryonic stem cell research in the USA.

Schlaeger TM, Lensch MW, Taylor PL.

Drug Discov Today. 2007 Apr;12(7-8):269-71. Epub 2007 Mar 1. No abstract available.

PMID:
17395086
48.

Unique sequence and expression profiles of rat galectins-5 and -9 as a result of species-specific gene divergence.

Lensch M, Lohr M, Russwurm R, Vidal M, Kaltner H, André S, Gabius HJ.

Int J Biochem Cell Biol. 2006;38(10):1741-58. Epub 2006 Apr 28.

PMID:
16740401
49.
50.

Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells.

Lensch MW, Daley GQ.

Blood. 2006 Apr 1;107(7):2605-12. Epub 2005 Dec 6. Review.

Supplemental Content

Loading ...
Support Center